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Letter

An ORFeome-based Analysis of Human
Transcription Factor Genes and the Construction
of a Microarray to Interrogate Their Expression
David N. Messina,1 Jarret Glasscock,1 Warren Gish, and Michael Lovett2
Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Transcription factors (TFs) are essential regulators of gene expression, and mutated TF genes have been shown to
cause numerous human genetic diseases. Yet to date, no single, comprehensive database of human TFs exists. In this
work, we describe the collection of an essentially complete set of TF genes from one depiction of the human
ORFeome, and the design of a microarray to interrogate their expression. Taking 1468 known TFs from TRANSFAC,
InterPro, and FlyBase, we used this seed set to search the ScriptSure human transcriptome database for additional
genes. ScriptSure’s genome-anchored transcript clusters allowed us to work with a nonredundant high-quality
representation of the human transcriptome. We used a high-stringency similarity search by using BLASTN, and a
protein motif search of the human ORFeome by using hidden Markov models of DNA-binding domains known to
occur exclusively or primarily in TFs. Four hundred ninety-four additional TF genes were identified in the overlap
between the two searches, bringing our estimate of the total number of human TFs to 1962. Zinc finger genes are by
far the most abundant family (762 members), followed by homeobox (199 members) and basic helix-loop-helix genes
(117 members). We designed a microarray of 50-mer oligonucleotide probes targeted to a unique region of the
coding sequence of each gene. We have successfully used this microarray to interrogate TF gene expression in species
as diverse as chickens and mice, as well as in humans.
[Supplemental material is available online at www.genome.org.]
Transcription factors (TFs) constitute a large and diverse group of
regulatory proteins that, in the typical case, bind to DNA relatively close to a target gene to activate or repress its transcription.
Gene regulation via TF binding is the primary mechanism by
which complex processes of development and differentiation are
controlled. In a recent review of 144 human developmental disorders in which the function of the causative gene had been
identified, 49 (34%) were due to mutated TF genes, a number
nearly double that of the next largest class (Boyadiev and Jabs
2000). The activity of TFs that are developmental regulators is
commonly controlled at the level of mRNA synthesis (Semenza
1998). In contrast, many of the TFs that regulate physiological
targets are constitutively present, and their activity is determined
by posttranslational modifications such as phosphorylation (Semenza 1998; Brivanlou and Darnell 2002). Nevertheless, some of
these latter classes of TFs have also been found to be developmentally regulated at the transcriptional level (Ranger et al 1998;
Crabtree 1999).
There are two major types of TFs in eukaryotes. The first are
those that participate in the ordered assembly of RNA polymerase
II transcription-initiation complexes, which include the general
TFs, coactivators, corepressors, and chromatin and histone modifiers. The second type are those that activate or repress the trans
cription of particular genes directly by binding to characteristic
regulatory sites (for reviews, see Lemon and Tjian 2000; Brivanlou and Darnell 2002). The groups that sequenced the human
genome estimated that there are between two and three thousand TFs in the human genome (International Human Genome
Sequencing Consortium 2001; Venter et al. 2001). However, this
1
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was only an estimate, and to date, no study has cataloged the
entire TF gene content of man.
In the current report, we sought to identify the vast majority
of human TFs with the intention of using this collection of sequences to design a more comprehensive microarray than is currently available for expression profiling this important set of
regulatory genes. Furthermore, by designing oligonucleotide
probes from the coding regions of these genes, we sought to use
this same array to study TF expression in closely related organisms, such as mouse and chicken.

RESULTS
The initial informatics component of this study consisted of two
steps: collecting a set of known human TFs (a seed set) and then
using that seed set to search for additional uncharacterized TFs in
the human transcriptome and ORFeome as defined by the ScriptSure collection of genome-nucleated expressed sequence tags
(ESTs).

Known Human TFs
Figure 1 shows our strategy for building a set of known human
TFs. We gathered known genes from three sources: TRANSFAC
(http://www.gene-regulation.com; Wingender et al. 2000), InterPro (http://www.ebi.ac.uk/interpro/; Apweiler et al. 2001), and
FlyBase (FlyBase Consortium 1999). TRANSFAC was chosen as a
starting point because it is a pre-existing database devoted to the
listing and binding characteristics of numerous TFs. The freely
available version of TRANSFAC contained records for 479 human
TF genes. InterPro was searched for human proteins that met the
Gene Ontology (GO; http://www.geneontology.org) project definition of a TF (The Gene Ontology Consortium 2000). This resulted in the identification of 852 InterPro entries. We next
turned to a well-studied organism with a fully sequenced genome
that had been annotated with GO identifiers. At the time this
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Figure 1 Creation of the seed set. Known TF genes were gathered from
three databases: TRANSFAC, InterPro, and FlyBase. Each gene was manually confirmed to be described as a TF in the literature or annotated as a
TF in LocusLink. After removing redundancies and adding some known
TFs that were not present in our source databases, our seed set of human
TFs contained 1468 members.

work was performed, the human genome and the GO annotations of it were incomplete. The best available GO-annotated
eukaryotic genome was Drosophila melanogaster, as represented
in FlyBase (http:///flybase.bio.indiana.edu/). FlyBase contained
932 genes annotated as encoding TFs. For most of these, FlyBase
listed human orthologs, and those it omitted were obtained via
Homologene (Zhang et al. 2000).
Genes gathered from the three sources were merged into
one list, and redundancies were eliminated. In some cases, not
every member of a known TF gene family was present in the
nonredundant set. For example, LocusLink lists eight known human members of the chromobox gene family (CBX1–8), but we
identified only three of these from TRANSFAC, InterPro, and FlyBase combined. In this case we manually added the five missing
CBX genes to our initial list. At this stage we also eliminated core
components of RNA and DNA polymerases from our seed set,
because these are ubiquitously and highly expressed. The resulting nonredundant seed set of human TF genes contained 1468
members.

Identifying Homologous Transcript Clusters
To identify more potential TF genes, we searched the ScriptSure
transcript database (http://sapiens.wustl.edu/ScriptSure; J. Glasscock and W. Gish, in prep.). ScriptSure is a database of genomeanchored human transcript clusters (ESTs, mRNAs, and RefSeqs).
ScriptSure clusters were built by using the genomic DNA sequence as a scaffold onto which transcripts were then aligned.
Contaminants such as chimeric sequences and incorrect submissions were thus filtered out when they failed to correctly align to
the genomic sequence. After passing strict criteria of minimum
length and similarity to the genome, each EST was assigned to
the locus with the highest scoring alignment in the genome,
thereby reducing cases in which highly similar but distinct sequences merged into a single cluster. Overlapping EST-to-genome
alignments created a genome-anchored transcript cluster. The
underlying high-quality genomic sequence was used as the cluster consensus. These factors translate into a database that is less
redundant, less contaminated, and composed of higher-quality
sequence than are other available databases. We chose to search
only the ScriptSure clusters that were annotated as spliced with
multiple underlying transcripts to eliminate the spurious identification of processed pseudogenes (frequent for TFs in the human
genome; Harrison et al. 2002; Zhang et al. 2003) and to eliminate
rare and possibly spurious transcription events. Although this
step ensures a high-quality data set, it will also inevitably result
in a failure to identify any TFs that are encoded by single-exon
genes, or TFs that are only rarely represented in the EST databases
(for more on these points, see Discussion).
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We were able to match 1361 of our 1468 TF sequences with
ScriptSure clusters (92.7%). Thus, we failed to identify 107 genes
out of our seed set within ScriptSure. This occurred because the
version of ScriptSure we used was built on a draft genome assembly (International Human Genome Sequencing Consortium 2001)
in which there were still gaps. However, this number is useful,
because it provides us with an estimate of the rate of false negatives in our overall BLASTN analysis (7.3%).
Two methods of searching ScriptSure were used: a highstringency BLASTN (http://blast.wustl.edu) of ScriptSure with
each seed TF, and a query of each ScriptSure transcript, conceptually translated, against a collection of TF DNA-binding hidden
Markov models (HMMs) extracted from Pfam (Fig. 2). We reasoned that the combination of these two approaches would provide a balance between sensitivity and specificity. The BLASTN
search alone would yield false positives, and requiring each candidate to have a TF’s DNA-binding domain would alleviate that
problem. The conservative combination of these two search
methods will, however, result in some false negatives (discussed
below) and an overall slight underestimate of the total TF gene
content.
A repeat-masked version of the 1468 TF seed sequences was
used as a BLASTN query against the complete ScriptSure database.
The query identified 5130 potential new TF candidate clusters
that met our criteria. The bit score cutoff used in the analysis was
determined from our analysis of a bit score distribution of HOX
gene family members (see Methods). We next filtered out clusters
that contained no introns (possible spurious alignments to processed pseudogenes) and clusters that were represented by only
one or two aligned ESTs. The number of newly identified clusters
that passed through this filter was 3338.

Further Selection Through TF Pfam Signatures
We were concerned that our ScriptSure BLASTN searches would
yield false positives from homologies within conserved domains
that are not TF-specific, such as protein–protein interaction domains. Therefore, we sought to select the clusters that contained
bona fide TF protein motifs. The database used in this analysis
was a subset of Pfam, containing DNA-binding domains found
in TF genes (see Methods). We searched the entire set of
“Spliced ⱍ Multiple” ScriptSure clusters (i.e., >22,000 clusters and
not just the 3338 clusters identified by BLASTN) for Pfam TF
DNA-binding motifs and found 3748 clusters that contained at
least one TF protein motif. These clusters included 1236 out of
the 1369 seed set present in ScriptSure, indicating that this Pfam
method has a false-negative rate of ∼10%. Therefore, the Pfam
search identified 2512 new putative TFs. Because the HMM used
in our Pfam search used a relatively low cutoff for motif similarities, we expected to also detect false positives by this route. To

Figure 2 Search for paralogous TFs. By using the seed set of 1468
known human TF genes, we searched ScriptSure, a representation of the
human transcriptome, using two methods: a high-stringency BLASTN
search and an hmmpfam search for DNA-binding domains known to
occur exclusively or primarily in TFs. The BLASTN search netted 3338
additional potential TFs, the domain search 2512. There were 494 genes
that were found with both search methods; these 494 comprise the
“found” set of human TF genes.
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remove these and the BLASTN false positives, we tested for overlaps between the results from the two search methods. The
overlap between the 3338 BLASTN clusters
and the 2512 Pfam clusters comprised 494
clusters (Fig. 2). These 494 newfound clusters, plus the 1468 seed set constituted a total of 1962 potential TF gene sequences. Interestingly, when all of the ESTs comprising
the 1962 potential TF sequences were compared with all spliced EST clusters from
ScriptSure, we found that the medians of
the two distributions were significantly different. The putative TF set had a threefold
higher level of alternative splice forms
when compared with the non-TF set, suggesting that extensive potential isoform diversity may be encoded by this set as a
whole. These genes and their accession
numbers are listed in the online Supplemental material.

Genomic Localizations of TF Genes
Tight clustering of genes is sometimes indicative of coregulated gene expression
(Boutanaev et al. 2002; Lercher et al. 2002).
For TFs in particular, there are precedents
for biologically significant clusters of HOX
genes on human chromosomes 7, 17, 12,
and 2. We sought to determine if the newly
identified set of putative TF genes were distributed randomly throughout the human
genome or were found to cluster at discrete
chromosomal locations.
Because heterochromatic and euchromatic regions of the genome are known to Figure 3 Genomic locations of TF clusters. Clusters of TF genes are shown on an ideogram
be relatively gene-poor and gene-rich, re- representation of the 24 human chromosomes. As shown in the legend at the top right, the four
canonical Hox gene clusters are shown in blue, the previously described chromosome 19 zinc finger
spectively, apparent clustering of genes was gene clusters are shown in green, and putative TF clusters identified in this study are shown in red.
expected (International Human Genome
The number in parentheses following each in the legend indicates the number of each type of
Sequencing Consortium 2001). Taking this cluster shown in this figure. Clusters containing known genes are labeled. Labels are not included
into consideration, we measured how often for hypothetical and unnamed genes, and so clusters consisting entirely of these are unlabeled. For
we observed three or more TF genes appear- a list of the genes comprising each cluster, see Supplemental materials.
ing in a window of eight clusters, translatchoice in this situation is to target the 3⬘ untranslated region
ing to a probability of 0.37 under a binomial model (Fig. 3). This
(3⬘ UTR), which is usually the most evolutionarily divergent reanalysis identified 29 regions that passed the criteria. Four of
gion in a transcript. However, our intention in building a TF
these regions were Hox clusters, and another nine clusters were
microarray was to use it across species, at least for organisms that
attributed to zinc finger clusters on chromosome 19 (19p12,
are evolutionarily close enough to retain a high degree of se19q13.2, and 19q34; Eichler et al. 1998). The remaining 16 clusquence similarity, such as the mouse and the chicken. Therefore,
ters had little underlying annotation of their transcript members.
we chose to design 50-mer oligonucleotide probes from within
Interestingly, a comparison of the 29 clusters with the completed
each coding region (determined by conceptual translation of
mouse genomic DNA sequence revealed that 18 out of the 29
each putative TF) and as 3⬘ as possible within the coding sewere conserved in the mouse, supporting the notion that there
quence. It should be noted that designing probes far away from
may be functional reasons for some of this clustering. For a list of
the 3⬘ ends of genes may result in a significant loss of sensitivity
the genes comprising each putative cluster, see Supplemental
when used with 3⬘ biased amplification protocols. One way to
materials.
circumvent this potential limitation is to use alternative ampliMicroarray Design
fication methods such as full-length amplification (Castle et al.
From the set of 1962 TF genes, we designed a microarray of 502003). We also selected these probes to be matched for Tm (Li and
mer oligonucleotide probes with which to interrogate their exStormo 2001). These probes are listed in Supplemental materials.
pression. One of the major issues in designing a microarray of TFs
This array has been successfully used to interrogate TF gene exis that many of these genes fall into families that share significant
pression across species as distant as chicken, mouse, and man
regions of conserved sequence homology. For example, there are
(Hawkins et al. 2003).
>500 TFs that contain zinc finger domains (Eichler et al. 1998;
DISCUSSION
this study, see below). To design a probe that will measure the
expression of only one gene, it was necessary to identify seIn this study we collected a set of known human TFs and used
quence regions in each gene that were unique to it. The obvious
two complementary computational methods to search the hu-
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man transcriptome for the entire set of human TF genes. Our
analysis identified 1962 putative TF genes, a number that correlates well with previous estimates (International Human Genome
Sequencing Consortium 2001; Venter et al. 2001).
This number is an estimate, but our seed set searches provide us with some idea of the error rates in that estimate. To
count a gene as a TF, we required that it must either be previously
annotated or described as such in the literature (the seed set), or
be paralogous to a known TF gene and contain a DNA-binding
domain known to occur exclusively or primarily in TFs (the
found set). The term “transcription factor” encompasses many
types of proteins. Those factors that do not bind directly to DNA
are likely to be underrepresented in our analysis. However, our
seed set did contain some non–DNA-binding TFs that had been
experimentally verified and described in the literature.
There are four variables that influence our estimate of total
TF genes: gaps in the human genome sequence, the incompleteness of Pfam, the degree of comprehensiveness of dbEST, and the
exclusion of single-exon predicted genes from our analysis. Our
finding that ∼7% of our 1468 input seed set failed to find matches
in the genome-nucleated ScriptSure database indicates that we
may be missing ∼35 genes in our “new” set of 494 at this filtering
step. We also found that ∼10% of our seed set ScriptSure matches
failed the Pfam criteria. Among these are oddities such as Mycbinding protein 1 (MBP-1), an alternate translation product of
the glycolytic enzyme ␣-enolase (ENO1; Feo et al. 2000), and a
bona fide TF that has been shown to bind to the c-myc P2 promoter and repress transcription of a reporter gene (Ray and Miller
1991; Subramanian and Miller 2000). Querying the MBP-1
mRNA sequence against the Pfam database, even at low stringency, yields no match to a known DNA-binding domain (data
not shown). We would estimate that perhaps a further 50 genes
(10% of the 494) may have failed this Pfam criteria. We can also
make some estimate of the error rates inherent in confining our
analysis to multi-exon genes and multiple ESTs. Multi-exon
genes encode ∼92% of our original seed set genes. Choosing to
work with the higher confidence spliced clusters in our analysis
may have resulted in excluding ∼8% of the single exon TF genes
in our found set. This 8% translates to 40 genes. EST databases
appear to be quite comprehensive in terms of TF coverage. A
survey of the rate of new TF discovery (using our seed set ScriptSure clusters as a benchmark) indicates that 92% of our clusters
were represented as early as 1997 (data not shown). Rate of discovery after this year has declined drastically. Nevertheless, it
remains possible that some transiently expressed or low abundance TF mRNAs remain to be discovered. Taken together, these
variables indicate that our analysis may have missed ∼130 TF
genes (6.6% of our total estimate).
Table 1 shows a summary of the human TF genes we have
found, classified by family. This table also shows the TF gene
content of three other completed eukaryotic genomes: Saccharomyces cerevisiae, Caenorhabditis elegans, and Drosophila melanogaster. Zinc-binding TFs constitute the largest class, amounting to
over one-third of all human TF genes. Homeobox-containing
genes are the second largest family, with ∼200 members. The
forkhead family has also expanded substantially in humans compared with the other species. This latter finding is of particular
interest, as many of the metazoan-specific forkhead genes show
tissue-specific expression and are involved in cell-type determination and differentiation (for review, see Carlsson and Mahlapuu 2002). For example, in the vertebrate embryo, forkhead
genes are required for the development of the notochord (Hoodless et al. 2001; Yamamoto et al. 2001) and patterning of paraxial
mesoderm and somites (Kume et al. 2001). Another forkhead
gene (FOXP2) has been implicated in the ability to develop language (Enard et al. 2002). The “other” category in Table 1 con-
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tains a mixture of genes, mostly members of the core transcriptional machinery, and the “structural” category includes genes
that are thought to regulate transcription by altering chromatin
structure, such as the HMGA family (for review, see Reeves 2001).
Looking at the data listed in Table 1 in another way, we can
estimate the proportion of the total transcriptome that encodes
TFs in each of the four species (Table 2). We do not know the
precise gene content of all of these species, but assuming that
current numbers are approximately correct, it appears that TFs
account for between 8% and 9% of all human genes. As one
might expect, we see an upward trend in the proportion of TFs as
the complexity of the organism increases. The development of
more, and more finely tuned, regulatory mechanisms in higher
eukaryotes has been hypothesized to explain their greater biological sophistication (Huang et al. 1999; Claverie 2001). This
idea has been expounded upon in many recent studies in which
“evolvability” (Kirschner and Gerhart 1998) and the evolution of
development (Jacob 2001; Revilla-I-Domingo and Davidson
2003; Wray 2003) have been linked to increased complexity in
regulatory networks. Our observation that humans devote at
least 8% of their ORFeome to primary regulators of transcription
(a number that is probably an underestimate given the levels of
alternative splicing in TF genes) is consistent with the idea that
developmental and body plan complexity are related to complexity in transcriptional regulatory networks.
The TF microarray we describe here is a versatile tool widely
applicable to many areas of biological research. Two key features
distinguish it from other microarrays. First, no other array described to date has probes for measuring the expression of as
many TF genes. The Affymetrix U133 Genechip set, a large and
commonly used human gene microarray, contains probes for
∼85% of the TF genes represented on this array (C. Helms, D.
Messina, and M. Lovett, unpubl.). Second, although our probes
were designed by using human DNA sequences, they represent
coding sequences and not 3⬘ UTR. Thus, this microarray can (and
has) been used to successfully measure TF gene expression in
other species, including mouse and chicken (Hawkins et al.
2003). The evolutionary distance to the last common ancestor of
human and chicken is ∼310 million years (Ureta-Vidal et al.
2003). Based on this distance, we would expect the TF array to be
useful for studies in many vertebrate species, including chimpanzee, rhesus monkey, rat, dog, cat, horse, pig, cow, and sheep. A
comparison of a random sampling of 50 TF genes from chicken
and zebrafish to our collection of oligonucleotides revealed an
average of 84% nucleotide identity for chicken and 79% nucleotide identity for zebrafish (diverged by 450 million years from
human). Thus, this array may also prove useful for more divergent species such as zebrafish, pufferfish, and frog. However, we
would urge caution in applying this tool to species more diverged
than chicken. In these cases the rate of false negatives will increase (i.e., 50-mer oligonucleotides that fail to match their orthologous gene) and decreased hybridization stringencies will
lead to an overall compression of dynamic range. Careful validation steps, and tuning of hybridization conditions, are required
in all of these cross-species applications.

METHODS
Seed List
To build an initial set of TFs for the array, we gathered records
from TRANSFAC (version 4.09-public; Wingender et al. 2000).
The version of TRANSFAC we used did not have references to
commonly used sequence identifiers, such as SWISS-PROT or
GenBank sequence records. Therefore, we took gene names and
descriptions from TRANSFAC records and correlated them by
hand with GenBank records, from which we were able to obtain
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Table 1.

A Comparison of Transcription Factors in Selected Eukaryotes
Homo sapiens

Gene family

Seed

Found

All

S.c.

C.e.

D.m.

Zinc bindinga,b
Homeobox
BHLH
␤-Scaffolda
BZip
NHR
Trp cluster
Forkhead
Bromodomaina
T-box
Jumonji
E2F
Dwarfin
Paired box
Heat shock
Tubbya
AF-4b
RFX
Methyl-CpG-bindinga
AP-2
TEAa
Pocket domain (Rb)a
GCMc,d
Other
Coactivators and corepressors
Structural
Total

422
186
92
77
59
49
38
36
14
16
6
9
9
9
6
5
7
6
4
4
4
3
2
214
111
80
1468

340
13
25
10
13
0
8
4
3
1
7
1
0
0
2
2
0
0
1
0
0
0
0
14
11
39
494

762
199
117
87
72
49
46
40
17
17
13
10
9
9
8
7
7
6
5
4
4
3
2
228
122
119
1962

139
9
8
11
21
0
10
4
10
0
1
0
0
0
5
0
0
1
0
0
5
0
0
—
—
—
224

309
84
25
34
25
252
13
15
13
21
1
4
3
7
1
1
0
1
2
4
5
1
0
—
—
—
821

420
103
46
45
21
21
14
18
16
8
2
3
3
5
1
1
2
1
4
1
5
2
2
—
—
—
744

The set of transcription factors is shown for four species, divided into families by the type of DNA-binding domain present
and sorted by abundance in human. The data for human transcription factors show the seed and found set numbers
separately, as well as the total number from the two sets added together. The Homo sapiens data are from this study. Unless
otherwise specified, the data for S. cerevisiae, C. elegans, and D. melanogaster are from Riechmann et al. (2000). bHLH
indicates basic helix-loop-helix; bZip, basic leucine zipper; C.e., Caenorhabditis elegans; D.m., Drosophila melanogaster;
GCM, glial cell missing; NHR, nuclear hormone receptor; RFX, regulatory factor X; S.c., Saccharomyces cerevisiae; TEA,
transcriptional enhancer activator (TEA/ATTS); and Trp cluster, tryptophan cluster.
a
S. cerevisiae, C. elegans, and D. melanogaster data on zinc binding subfamilies AN1, BTB/POZ-containing, MYND, and
PHD, ␤-scaffold subfamily cold shock, bromodomain family, Tubby family, methyl-CpG-binding family, TEA family, and
pocket domain (Rb) family from Rubin et al. (2000); supplemental information (http://www.sciencemag.org/feature/data/
1049664.shl).
b
S. cerevisiae, C. elegans, and D. melanogaster data on zinc binding subfamily MIZ and AF-4 family from “species distribution” feature of Pfam Web site (http://pfam.wustl.edu).
c
D. melanogaster data on GCM family from Akiyama et al. (1996).
d
S. cerevisiae and C. elegans data on GCM family from “species distribution” feature of Pfam Web site
(http://pfam.wustl.edu).

mRNA sequences. It should be noted that the latest version of
TRANSFAC (TRANSFAC 6.0; Matys et al. 2003) contains more
entries than the version we used, but when different splice forms
are eliminated, these all appear to overlap with our final set of
genes. Additional human TFs were extracted from InterPro (Apweiler et al. 2001) and FlyBase Consortium (1999). We searched
InterPro for all records annotated as “human” and occurring at or
below the “transcription factor” node of the GO hierarchy (GO
ID 0003700). InterPro records contain protein, not mRNA sequence. We therefore used LocusLink (http://www.ncbi.nlm.nih.
gov/LocusLink/) to identify the GenBank mRNA records that correspond to the EMBL protein identification in the InterPro record. If available, we chose mRNA sequences from the RefSeq
database (Pruitt and Maglott 2001); RefSeqs comprise the majority of our set (1270/1468). Otherwise, we took the most complete
GenBank mRNA sequence or EST representing that gene (198/
1468). For four genes (GSH1, HMX3, DLX1, and CHX10), the
best available sequences were RefSeq gene models (see http://
www.ncbi.nlm.nih.gov/LocusLink/refseq.html for description).
Thirteen genes were extracted from genomic sequence, and two
(GSC and HMX2) were obtained from an Ensembl gene model
(http://www.ensembl.org). For zinc finger genes, we manually

removed subclasses of zinc finger proteins that are known not to
bind DNA. However, it is possible that some of the zinc binding
TFs in our final set will later be determined to be non–DNAbinding.
Additional known TF family members not identified by the
above procedures were identified by using LocusLink or extensive
literature searches and added to our database. Once data from
these multiple sources have been collected, duplicates were eliminated, yielding a set of 1468 known human TFs (http://hg.wustl.
edu/lovett/projects/nohr/Tfarray.html/).

Homologous Transcript Clusters
Each initial seed list member (Fig. 1) was matched to its best
ScriptSure cluster, requiring a lower bound of 90% coverage of
the seed sequence and 80% identity in the alignment between
the seed sequence and the ScriptSure cluster. The 1369 seed sequences found to have a matching ScriptSure cluster were then
masked for repetitive sequence. RepeatMasker with the parameters “-w ⳮs ⳮno_is ⳮxsmall” was used for one round of masking, identifying interspersed repeats. RepeatMasker was used
again in a separate round of masking by using the parameters
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match the transcription subset of the Pfam database with a P
value of ⱕ0.0001; 2512 of these were clusters that did not match
our seed list.

Table 2. Transcription Factors as a Proportion of Total
Gene Content

Organism

Approximate
number of genes
(TFs/total)

Percent

224/6569a
824/19546b
744/13525c
1962/24652d
1962/21787e

3.4%
4.2%
5.5%
8.0%
9.0%

S. cerevisiae
C. elegans
D. melanogaster
H. sapiens (NCBI)
H. sapiens (Ensembl)

Mapping TFs to Genomic Contigs

The number of transcription factor genes for S. cerevisiae, C. elegans,
D. melanogaster, and H. sapiens is shown, divided by the approximate
total number of genes for each organism, to estimate the percentage
of the total gene content that transcription factor genes represent.
Two estimates are given for H. sapiens, based on current gene predictions from Ensembl and NCBI. Transcription factor gene counts are
the same as in Table 1. Total gene count sources are as follows: aSGD
(July 2003), http://www.yeastgenome.org/VL-FAQ.html; bEnsembl C.
elegans v19.102.1 (December 16, 2003), excluding 442 pseudogenes,
http://www.ensembl.org/Caenorhabditis_elegans/stats/; cEnsembl
D. melanogaster v19.3a.1 (January 7, 2003), http://www.ensembl.
org/Drosophila_melanogaster/stats/; dNCBI human genome assembly build 34 (July 2003), http://www.ncbi.nlm.nih.gov/mapview/
stats/BuildStats.cgi?taxid=9606&build=34&ver=1, and eEnsembl v19
build 34a (December 16, 2003), excluding 1744 pseudogenes,
http://www.ensembl.org/Homo_sapiens/stats/.

“-s ⳮnoint ⳮno_is ⳮxsmall”; this works best for masking simple
repeats. Lastly, low complexity sequence was masked by using
nseg with the parameters “12 1.0 1.0 ⳮz 1 ⳮx”. A merge was
performed on the results of these three masks, resulting in one
tri-masked sequence for each of the 1369 seed sequences.
The tri-masked sequences were used in a BLASTN query
against the complete ScriptSure database. WU-BLAST BLASTN 2.0
was used with the parameters “-S = 200 S2 = 100 gapS2 = 200 X = 26
gapX = 55 W = 11 gapW = 18 gapall Q = 11 R = 11 M = 5 N = ⳮ11
Z = 300000000 Y = 3000000000 V = 10000 B = 10000 gi novalidctxok nonnegok hspsepqmax = 200000 gapsepqmax = 1000000
lcmask topcomboN = 1 hspmax = 5000 -wordmask dust ⳮmaskextra 15”. The seed set genes were subtracted out of the
“Spliced|Multiple” results leaving 3338 potential additional TFs
identified by the BLASTN search.

The Human Genome Consortium’s June 2002 draft of the human genome was used as the template for the version of ScriptSure we used in our analysis (June 2002b). Therefore, this same
draft of the genome was used to place our identified clusters back
onto the genome. The TF genes in our seed set as well as those
identified in the overlap of the BLASTN and Pfam analysis were
mapped back to the genome (1968 clusters total). Because ScriptSure reports its cluster coordinates relative to genomic contigs
(rather than chromosome coordinates), UCSC’s “lft” file was used
to translate between contig and chromosome coordinates
(http://genome.ucsc.edu). Loci were considered significant if
three TF clusters were found in a colinear cluster of eight total
clusters (P = 0.37 under binomial model).

Oligonucleotide Probe Design
For each TF we identified, we designed a 50-mer to represent that
gene on our array. We designed probes with four criteria: (1) the
probe must be from a unique region of the sequence of a gene to
eliminate potential cross-hybridization to other genes; (2) to allow use of the array on nonhuman samples, the probe must be
from protein coding sequence (CDS); (3) the design was targeted
to a region of coding sequence as 3⬘ as possible; and (4) the
probes were matched for melting temperatures (Tm). The vast
majority of probes had a Tm of 72°C, with very occasionally a
probe varying by as much as 3°C when severe design constraints
existed. We were able to automate the selection of probes meeting criteria 1 and 4 with a microarray probe design program,
Probes2 (Li and Stormo 2001); the other steps were semiautomated with custom Perl scripts. The Sanger Centre/Ensembl set
of 27,395 verified human cDNA sequences (downloaded on July
14, 2001, current version available at ftp://ftp.ensembl.org/pub/
current_human/data/fasta/cdna/) was used in conjunction with
Probes2 to identify unique regions of each gene and design 50mer probes. After candidate probes meeting these criteria were
generated, we performed BLASTN similarity searches (default parameters) against the human genome sequence and inspected
the results manually to confirm all criteria were met. Probes were
synthesized (Sigma Genosys), resuspended at 60 µM in 1.5 M
betaine and 6% DMSO, and spotted in duplicate on poly-L-lysine
coated microscope slides with a GMS-417 arrayer (Affymetrix).

Bit Score Cutoff
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Pfam TF Clusters
The starting point for this analysis was all the ScriptSure clusters
that originated from spliced transcript clusters with multiple underlying transcripts (a total of 22,086 clusters). These clusters
were translated in all six reading frames to amino acid sequences.
The translated products were then searched by using hmmpfam
from the HMMER 2.2 package (http://hmmer.wustl.edu). The database used in this query was a subset of the Pfam 7.1 database,
the members (398) of which were annotated with the terms
“DNA binding” or “transcription” (http://pfam.wustl.edu); 3748
clusters of the 22,086 clusters searched (17%) were found to
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